Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05522296Completed

Break-through Infection Following Mpox vaccinatIon

Role: collaborator

NCT05744492Not ApplicableUnknown

Multicomponent Exercise Program on the Intrinsic Capacity (ICOPE) of Community-dwelling Older Adults in Primary Care

Role: collaborator

NCT02110030Not ApplicableCompleted

Effectiveness of Two Electrotherapy Techniques to Treat Subacromial Impingement Syndrome

Role: collaborator

NCT02297685Not ApplicableCompleted

Effectiveness of Electrotherapy Techniques to Treat Low Back Pain

Role: collaborator

NCT00131079Phase 3Completed

PEPAF: Evaluation of Family Physician's Effectiveness for Physical Activity Promotion

Role: collaborator

NCT00146315Phase 3Completed

ESCAP: Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting

Role: collaborator

NCT00624533Phase 2Completed

Efficiency of GDS Method for Lumbar Stabilization for Non-Specific Low Back Pain in Primary Care

Role: collaborator

All 7 trials loaded